论文信息 - Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England - 字舞流文

Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England

Several studies have found increased risks of thrombosis with thrombocytopenia syndrome (TTS) following the ChAdOx1 vaccination. However, case ascertainment is often incomplete in large electronic health record (EHR)‐based studies.

C. Atchison | M. Ramsay | S. Booth | B. Hunt | P. Maccallum | G. Amirthalingam | J. Stowe | N. Andrews | M. Desborough | Shoshana Burke | D. Khan | V. Mcdonald | K. Breen | S. Shapiro | Heather Leary | J. Dhanapal | E. Hutchinson | A. Hackett | Hannah Higgins | Gurpreet Bahra | Connor Sweeney | C. Lees | Ngai Mun Aiman Entwistle

[1] N. Andrews,et al. Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England , 2021, The Lancet Regional Health - Europe.

[2] K. Khunti,et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study , 2021, BMJ.

[3] P. McKeigue,et al. Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland , 2021, BMC Infectious Diseases.

[4] Spiros C. Denaxas,et al. Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, and thrombocytopenic events: whole population cohort study in 46 million adults in England , 2021, medRxiv.

[5] G. Ambler,et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis , 2021, The New England journal of medicine.

[6] E. Coma,et al. Vaccines against Covid-19, venous thromboembolism, and thrombocytopenia. A population-based retrospective cohort study , 2021, medRxiv.

[7] P. Choi. Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. , 2021, The New England journal of medicine.

[8] anonymous,et al. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia , 2021, Thrombosis Research.

[9] S. de Lusignan,et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland , 2021, Nature Medicine.

[10] K. Verhamme,et al. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 20.6 million people in six European countries , 2021, medRxiv.

[11] H. Sørensen,et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study , 2021, BMJ.

[12] Fridtjof Lund-Johansen,et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination , 2021, The New England journal of medicine.

[13] Heather J Whitaker,et al. The methodology of self-controlled case series studies , 2009, Statistical methods in medical research.